Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Palliation
Do you modify the whole brain radiation dose if a patient has previously been treated with SRS for brain metastases?
Related Questions
Do you have a 15 fraction constraint for the LADA?
Does your choice of dose and fractionation for bone metastasis depend on the location of the metastasis in question?
Can palliative radiation be used to treat recurrent malignant pleural effusion in NSCLC?
Is it safe to re-irradiate non-spine bone metastases with SBRT if they received previous SBRT?
How would you manage a patient with a high-risk asymptomatic bone metastasis with a driver mutation?
Would you consider spine re-irradiation after Pluvicto?
Would you offer SRS to a hippocampal metastasis in a patient with ES-SCLC treated with prior WBRT?
Do you constrain heterogeneity or hotspots when delivering spine SBRT for bone metastases?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
Would you offer 12-16 Gy in a single fraction for a symptomatic, non-vertebral bone metastasis?